Saltire Capital Ltd. (TSX: SLT) (TSX: SLT.U) (TSX: SLT.WT.U) (TSX: SLT.WT) ("Saltire" or the "Company") today reported its unaudited condensed consolidated interim financial statements ("Financial ...
SAN FRANCISCO, November 03, 2025--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback